Palliative radiotherapy for lung cancer: Two versus five fractions
- 31 December 1997
- journal article
- clinical trial
- Published by Elsevier BV in Clinical Oncology
- Vol. 9 (2), 90-95
- https://doi.org/10.1016/s0936-6555(05)80446-7
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Randomized trial of palliative two-fraction versus more intensive 13-fraction radiotherapy for patients with inoperable non-small cell lung cancer and good performance statusClinical Oncology, 1996
- The impact of clinical trials on the treatment of lung cancerClinical Oncology, 1993
- Audit: The use of radiotherapy for NSCLC in the UKClinical Oncology, 1993
- A Medical Research Council (MRC) randomised trial of palliative radiotherapy with two fractions or a single fraction in patients with inoperable non-small-cell lung cancer (NSCLC) and poor performance statusBritish Journal of Cancer, 1992
- Inoperable non-small-cell lung cancer (NSCLC): a Medical Research Council randomised trial of palliative radiotherapy with two fractions or ten fractionsBritish Journal of Cancer, 1991
- An evaluation of the palliative role of radiotherapy in inoperable carcinoma of the bronchusClinical Radiology, 1988
- Palliative radiotherapy for inoperable carcinoma of the lung: Final report of a rtog multi-institutional trialInternational Journal of Radiation Oncology*Biology*Physics, 1985
- Short-Course Radiation Therapy in Carcinoma of the LungRadiology, 1970